Flex posts Q2 FY2018 earnings beat


Flex today posted second quarter 2018 earnings results that met expectations on Wall Street.

The San Jose, Calif.-based company posted profits of $205.1 million, or 38¢ per share, on sales of $6.3 billion for the 3 months ended September 30, seeing the bottom line swing from $2.5 million in the red while sales grew 4.4% compared with the same period last year.

Adjusted to exclude 1-time items, earnings per share were 27¢, just ahead of the 26¢ consensus on Wall Street, where analysts were expecting to see sales of $6.1 billion for the quarter.

“Our results this quarter strongly indicate Flex’s top-line growth, structural portfolio evolution, and capital return all remain on track. We had impressive revenue performance across the board, growing for the third consecutive quarter on a year-over-year basis, with revenue for all four business groups above the midpoint of their respective guidance ranges,” CEO Mike McNamara said in a press release.

The company updated its guidance for the upcoming third quarter, expecting to see revenues between $6.3 billion and $6.7 billion with adjusted earnings per share between 28¢ and 32¢.

Flex shares fell slightly today, down 1.6% to close at $17.35.

How do you know your technology is disruptive enough to break conventional wisdom?

textadimage Stan Rowe knows a little something about bringing disruptive technology to market. The current Edwards Lifesciences CSO was in on the ground floor of two of medtech's most disruptive treatments, stents and transcatheter aortic valve replacement.

On December 12th, Rowe will sit down with MassDevice editor Brad Perriello for a long ranging discussion about the inside story on how these technologies came to market and what Rowe learned along the way.

Register now with the code "TAVR" and save 15% today.

Speak Your Mind